Clinical Utility of Pharmacogenomics in the Management of Hepatitis C

Pharmacogenomics and Personalized Medicine - New Zealand
doi 10.2147/pgpm.s52624
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Leveraging the Utility of Pharmacogenomics in Psychiatry Through Clinical Decision Support: A Focus Group Study

Annals of General Psychiatry
PsychiatryMental Health
2019English

Clinical Pharmacogenomics

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Boceprevir and Telaprevir for the Treatment of Chronic Hepatitis C: Safety Management in Clinical Practice

Liver International
Hepatology
2011English

Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline

Hepatitis Monthly
HepatologyInfectious Diseases
2016English

Utility of HBsAg Quantification in Developing an Individualised Approach to the Management of Chronic Hepatitis B Virus in Clinical Practice

Gut
Gastroenterology
2011English

Clinical Utility of the Risperidone Formulations in the Management of Schizophrenia

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2011English

Clinical Impact of Pharmacogenomics

Drug Metabolism and Pharmacokinetics
1999English

A New Era in the Management of the Hepatitis C

International Journal of Clinical Medicine
2014English

Clinical Utility of Hepatocellular Carcinoma Risk Scores in Chronic Hepatitis B

Liver International
Hepatology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy